H Drugeon
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
- Endocrinology top 2%
Papers in
-
- Antibiotic Resistance in Bacteria 36
-
- Antibiotic Use and Resistance 9
- Co-authors
- Laurent PoirelPatrice NordmannStéphane CorvecJ. CaillonDaniela JabésAlexander TomaszJacques BilléPascale Bémer
- Journals
- Antimicrobial Agents and Chemotherapy (19 papers)Journal of Clinical Microbiology (4 papers)Journal of Antimicrobial Chemotherapy (4 papers)Chemotherapy (2 papers)Infection Control and Hospital Epidemiology (2 papers)
- Partner nations
- FranceCanadaUnited States
In The Last Decade
H Drugeon
71 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 105
- Molecular Medicine 633
- Endocrinology 267
- Clinical Biochemistry 263
- Infectious Diseases 694
- Applied Microbiology and Biotechnology 74
Countries citing papers authored by H Drugeon
This map shows the geographic impact of H Drugeon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Drugeon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Drugeon more than expected).
Fields of papers citing papers by H Drugeon
This network shows the impact of papers produced by H Drugeon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Drugeon. The network helps show where H Drugeon may publish in the future.
Co-authorship network
The 25 scholars most cited alongside H Drugeon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 0 | |
| 2 | 2008 | 33 | |
| 3 | 2008 | 10 | |
| 4 | 2008 | 4 | |
| 5 | 2007 | 64 | |
| 6 | 2006 | 2 | |
| 7 | 2006 | 7 | |
| 8 | 2005 | 3 | |
| 9 | 2005 | 101 | |
| 10 | 2004 | 1 | |
| 11 | 2004 | 0 | |
| 12 | 2004 | 2 | |
| 13 | 2003 | 15 | |
| 14 | 2002 | 13 | |
| 15 | 2001 | 1 | |
| 16 | 2000 | 62 | |
| 17 | 1995 | 2 | |
| 18 | 1994 | 6 | |
| 19 | 1994 | 21 | |
| 20 | 1987 | 16 |
About H Drugeon
H Drugeon is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology, Pharmacology, Clinical Biochemistry and Infectious Diseases, having authored 76 papers that have together received 1.7k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (39 papers), Antibiotic Resistance in Bacteria (36 papers), Antimicrobial Resistance in Staphylococcus (20 papers), Pneumonia and Respiratory Infections (14 papers), Bacterial Identification and Susceptibility Testing (13 papers), Mycobacterium research and diagnosis (9 papers), Antibiotic Use and Resistance (9 papers) and Tuberculosis Research and Epidemiology (8 papers). The work is most often cited by research in Molecular Medicine (633 citations), Endocrinology (267 citations), Clinical Biochemistry (263 citations), Infectious Diseases (694 citations) and Applied Microbiology and Biotechnology (74 citations). H Drugeon has collaborated with scholars based in France, Canada and United States. Frequent co-authors include Laurent Poirel, Patrice Nordmann, Stéphane Corvec, J. Caillon, Daniela Jabés, Alexander Tomasz, Jacques Billé, Pascale Bémer, Thierry Naas and Denis Baron. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Clinical Microbiology, Journal of Antimicrobial Chemotherapy, Chemotherapy and Infection Control and Hospital Epidemiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.